Type |
Details |
Score |
Allele |
Name: |
TRAF3 interacting protein 3; targeted mutation 1a, Wellcome Trust Sanger Institute |
Allele Type: |
Targeted |
Attribute String: |
Conditional ready, Null/knockout, Reporter |
|
•
•
•
•
•
|
Allele |
Name: |
TRAF3 interacting protein 3; targeted mutation 1e, Wellcome Trust Sanger Institute |
Allele Type: |
Targeted |
Attribute String: |
Null/knockout, Reporter |
|
•
•
•
•
•
|
Allele |
Name: |
TRAF3 interacting protein 2; targeted mutation 1a, Wellcome Trust Sanger Institute |
Allele Type: |
Targeted |
Attribute String: |
Conditional ready, Null/knockout, Reporter |
|
•
•
•
•
•
|
Allele |
Name: |
TRAF3 interacting protein 2; targeted mutation 1e, Wellcome Trust Sanger Institute |
Allele Type: |
Targeted |
Attribute String: |
Null/knockout, Reporter |
|
•
•
•
•
•
|
Strain |
Attribute String: |
spontaneous mutation, mutant strain, congenic |
|
•
•
•
•
•
|
Strain |
Attribute String: |
coisogenic, mutant strain, spontaneous mutation |
|
•
•
•
•
•
|
Strain |
Attribute String: |
spontaneous mutation, mutant strain, congenic |
|
•
•
•
•
•
|
Strain |
Attribute String: |
congenic, mutant strain, spontaneous mutation |
|
•
•
•
•
•
|
Strain |
Attribute String: |
mutant strain, congenic, spontaneous mutation |
|
•
•
•
•
•
|
Strain |
Attribute String: |
mutant strain, congenic, spontaneous mutation |
|
•
•
•
•
•
|
Strain |
Attribute String: |
congenic, mutant strain, spontaneous mutation |
|
•
•
•
•
•
|
Strain |
Attribute String: |
mutant stock, targeted mutation |
|
•
•
•
•
•
|
Allele |
Name: |
TRAF3 interacting protein 2; gene trap IST13832B10, Texas A&M Institute for Genomic Medicine |
Allele Type: |
Gene trapped |
|
|
•
•
•
•
•
|
Allele |
Name: |
TRAF3 interacting protein 2; gene trap IST13900D5, Texas A&M Institute for Genomic Medicine |
Allele Type: |
Gene trapped |
|
|
•
•
•
•
•
|
Allele |
Name: |
TRAF3 interacting protein 2; gene trap IST14206G3, Texas A&M Institute for Genomic Medicine |
Allele Type: |
Gene trapped |
|
|
•
•
•
•
•
|
Allele |
Name: |
TRAF3 interacting protein 2; gene trap IST14172G9, Texas A&M Institute for Genomic Medicine |
Allele Type: |
Gene trapped |
|
|
•
•
•
•
•
|
Allele |
Name: |
TRAF3 interacting protein 2; gene trap IST14219G5, Texas A&M Institute for Genomic Medicine |
Allele Type: |
Gene trapped |
|
|
•
•
•
•
•
|
Allele |
Name: |
TRAF3 interacting protein 1; gene trap IST14437C6, Texas A&M Institute for Genomic Medicine |
Allele Type: |
Gene trapped |
|
|
•
•
•
•
•
|
Allele |
Name: |
TRAF3 interacting protein 2; gene trap IST14582B8, Texas A&M Institute for Genomic Medicine |
Allele Type: |
Gene trapped |
|
|
•
•
•
•
•
|
Allele |
Name: |
TRAF3 interacting protein 2; gene trap IST14781A4, Texas A&M Institute for Genomic Medicine |
Allele Type: |
Gene trapped |
|
|
•
•
•
•
•
|
Allele |
Name: |
TRAF3 interacting protein 2; gene trap IST15080F5, Texas A&M Institute for Genomic Medicine |
Allele Type: |
Gene trapped |
|
|
•
•
•
•
•
|
Allele |
Name: |
TRAF3 interacting protein 1; targeted mutation 1a, Helmholtz Zentrum Muenchen GmbH |
Allele Type: |
Targeted |
Attribute String: |
Conditional ready, Null/knockout, Reporter |
|
•
•
•
•
•
|
Allele |
Name: |
TRAF3 interacting protein 1; targeted mutation 1e, Helmholtz Zentrum Muenchen GmbH |
Allele Type: |
Targeted |
Attribute String: |
Null/knockout, Reporter |
|
•
•
•
•
•
|
Allele |
Name: |
TRAF3 interacting protein 3; targeted mutation 1b, Wellcome Trust Sanger Institute |
Allele Type: |
Targeted |
Attribute String: |
Null/knockout, Reporter |
|
•
•
•
•
•
|
Allele |
Name: |
TRAF3 interacting protein 3; targeted mutation 1c, Wellcome Trust Sanger Institute |
Allele Type: |
Targeted |
Attribute String: |
Conditional ready |
|
•
•
•
•
•
|
Allele |
Name: |
TRAF3 interacting protein 1; endonuclease-mediated mutation 1, Baylor College of Medicine |
Allele Type: |
Endonuclease-mediated |
Attribute String: |
Null/knockout |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Traf3ip2/Traf3ip2 |
Background: |
involves: 129/Sv * BALB/c |
Zygosity: |
hm |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Traf3ip2/Traf3ip2 |
Background: |
either: B6.129-Traf3ip2 or (involves: 129) or (involves: 129 * BALB/c) |
Zygosity: |
hm |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Traf3ip2/Traf3ip2 |
Background: |
KOR-Traf3ip2 |
Zygosity: |
hm |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Traf3ip2/Traf3ip2 |
Background: |
C.KOR-Traf3ip2 |
Zygosity: |
hm |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Traf3ip2/Traf3ip2 |
Background: |
B6.KOR-Traf3ip2 |
Zygosity: |
hm |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Traf3ip2/Traf3ip2 |
Background: |
AK.KOR-Traf3ip2 |
Zygosity: |
hm |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Traf3ip2/Traf3ip2 |
Background: |
A.KOR-Traf3ip2 |
Zygosity: |
hm |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Traf3ip1/Traf3ip1 |
Background: |
involves: 129P2/OlaHsd * C57BL/6 |
Zygosity: |
hm |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Traf3ip2/Traf3ip2 |
Background: |
C.129-Traf3ip2 |
Zygosity: |
hm |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Traf3ip2/Traf3ip2 |
Background: |
B6.129-Traf3ip2 |
Zygosity: |
hm |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Traf3ip2/Traf3ip2 |
Background: |
involves: 129 * C57BL/6 |
Zygosity: |
hm |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Publication |
First Author: |
Majumder S |
Year: |
2019 |
Journal: |
Nat Immunol |
Title: |
IL-17 metabolically reprograms activated fibroblastic reticular cells for proliferation and survival. |
Volume: |
20 |
Issue: |
5 |
Pages: |
534-545 |
|
•
•
•
•
•
|
Publication |
First Author: |
Reynolds JM |
Year: |
2015 |
Journal: |
Immunity |
Title: |
Interleukin-17B Antagonizes Interleukin-25-Mediated Mucosal Inflammation. |
Volume: |
42 |
Issue: |
4 |
Pages: |
692-703 |
|
•
•
•
•
•
|
Publication |
First Author: |
Herjan T |
Year: |
2018 |
Journal: |
Nat Immunol |
Title: |
IL-17-receptor-associated adaptor Act1 directly stabilizes mRNAs to mediate IL-17 inflammatory signaling. |
Volume: |
19 |
Issue: |
4 |
Pages: |
354-365 |
|
•
•
•
•
•
|
Publication |
First Author: |
Wen J |
Year: |
2019 |
Journal: |
Mol Immunol |
Title: |
USP25 promotes endotoxin tolerance via suppressing K48-linked ubiquitination and degradation of TRAF3 in Kupffer cells. |
Volume: |
106 |
|
Pages: |
53-62 |
|
•
•
•
•
•
|
Publication |
First Author: |
Zhang P |
Year: |
2012 |
Journal: |
Sci Signal |
Title: |
Single amino acid substitutions confer the antiviral activity of the TRAF3 adaptor protein onto TRAF5. |
Volume: |
5 |
Issue: |
250 |
Pages: |
ra81 |
|
•
•
•
•
•
|
Publication |
First Author: |
Dadgostar H |
Year: |
2003 |
Journal: |
FEBS Lett |
Title: |
T3JAM, a novel protein that specifically interacts with TRAF3 and promotes the activation of JNK(1). |
Volume: |
553 |
Issue: |
3 |
Pages: |
403-7 |
|
•
•
•
•
•
|
Publication |
First Author: |
Chang SH |
Year: |
2011 |
Journal: |
Immunity |
Title: |
Interleukin-17C promotes Th17 cell responses and autoimmune disease via interleukin-17 receptor E. |
Volume: |
35 |
Issue: |
4 |
Pages: |
611-21 |
|
•
•
•
•
•
|
Publication |
First Author: |
Lee JS |
Year: |
2015 |
Journal: |
Immunity |
Title: |
Interleukin-23-Independent IL-17 Production Regulates Intestinal Epithelial Permeability. |
Volume: |
43 |
Issue: |
4 |
Pages: |
727-38 |
|
•
•
•
•
•
|
Publication |
First Author: |
Zepp JA |
Year: |
2017 |
Journal: |
J Immunol |
Title: |
IL-17A-Induced PLET1 Expression Contributes to Tissue Repair and Colon Tumorigenesis. |
Volume: |
199 |
Issue: |
11 |
Pages: |
3849-3857 |
|
•
•
•
•
•
|
Publication |
First Author: |
Taylor TC |
Year: |
2023 |
Journal: |
Cell Host Microbe |
Title: |
IκBζ is an essential mediator of immunity to oropharyngeal candidiasis. |
Volume: |
31 |
Issue: |
10 |
Pages: |
1700-1713.e4 |
|
•
•
•
•
•
|
Publication |
First Author: |
Wang C |
Year: |
2017 |
Journal: |
Nat Commun |
Title: |
IL-17 induced NOTCH1 activation in oligodendrocyte progenitor cells enhances proliferation and inflammatory gene expression. |
Volume: |
8 |
|
Pages: |
15508 |
|
•
•
•
•
•
|
Publication |
First Author: |
Lin X |
Year: |
2021 |
Journal: |
iScience |
Title: |
ORF8 contributes to cytokine storm during SARS-CoV-2 infection by activating IL-17 pathway. |
Volume: |
24 |
Issue: |
4 |
Pages: |
102293 |
|
•
•
•
•
•
|
Publication |
First Author: |
Kanamori M |
Year: |
2002 |
Journal: |
FEBS Lett |
Title: |
NF-kappaB activator Act1 associates with IL-1/Toll pathway adaptor molecule TRAF6. |
Volume: |
532 |
Issue: |
1-2 |
Pages: |
241-6 |
|
•
•
•
•
•
|
Publication |
First Author: |
Verma AH |
Year: |
2017 |
Journal: |
Sci Immunol |
Title: |
Oral epithelial cells orchestrate innate type 17 responses to Candida albicans through the virulence factor candidalysin. |
Volume: |
2 |
Issue: |
17 |
|
|
•
•
•
•
•
|
Publication |
First Author: |
Claudio E |
Year: |
2019 |
Journal: |
J Immunol |
Title: |
IL-25 Orchestrates Activation of Th Cells via Conventional Dendritic Cells in Tissue to Exacerbate Chronic House Dust Mite-Induced Asthma Pathology. |
Volume: |
203 |
Issue: |
8 |
Pages: |
2319-2327 |
|
•
•
•
•
•
|
Strain |
Attribute String: |
coisogenic, endonuclease-mediated mutation, mutant strain |
|
•
•
•
•
•
|
Strain |
Attribute String: |
mutant strain, coisogenic, targeted mutation |
|
•
•
•
•
•
|
Strain |
Attribute String: |
coisogenic, mutant strain, targeted mutation |
|
•
•
•
•
•
|
Strain |
Attribute String: |
coisogenic, targeted mutation |
|
•
•
•
•
•
|
Strain |
Attribute String: |
coisogenic, endonuclease-mediated mutation, mutant strain |
|
•
•
•
•
•
|
Strain |
Attribute String: |
coisogenic, targeted mutation |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Cd40/Cd40 Traf3ip2/Traf3ip2 |
Background: |
involves: 129 * 129P2/OlaHsd * BALB/c |
Zygosity: |
cx |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Traf3ip2/Traf3ip2 |
Background: |
involves: C57BL/6N |
Zygosity: |
hm |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Traf3ip3/Traf3ip3 |
Background: |
C57BL/6N-Traf3ip3/Wtsi |
Zygosity: |
hm |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Traf3ip3/Traf3ip3 |
Background: |
involves: BALB/cJ * C57BL/6N |
Zygosity: |
hm |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Traf3ip1/Traf3ip1 |
Background: |
C57BL/6N-Traf3ip1/BayMmucd |
Zygosity: |
hm |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Publication |
First Author: |
Huang J |
Year: |
2017 |
Journal: |
J Immunol |
Title: |
IL-17C/IL-17RE Augments T Cell Function in Autoimmune Hepatitis. |
Volume: |
198 |
Issue: |
2 |
Pages: |
669-680 |
|
•
•
•
•
•
|
Publication |
First Author: |
Lindstrom SI |
Year: |
2019 |
Journal: |
J Diabetes Complications |
Title: |
Diabetes induces IL-17A-Act1-FADD-dependent retinal endothelial cell death and capillary degeneration. |
Volume: |
33 |
Issue: |
9 |
Pages: |
668-674 |
|
•
•
•
•
•
|
Publication |
First Author: |
Zhang B |
Year: |
2013 |
Journal: |
J Immunol |
Title: |
Crystal structure of IL-17 receptor B SEFIR domain. |
Volume: |
190 |
Issue: |
5 |
Pages: |
2320-6 |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Fcgr2b/Fcgr2b Traf3ip2/Traf3ip2 |
Background: |
involves: 129 * 129S4/SvJae * C57BL/6 |
Zygosity: |
cx |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Traf3ip1/Traf3ip1<+> |
Background: |
C57BL/6N-Traf3ip1/BayMmucd |
Zygosity: |
ht |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Ptch1/Ptch1<+> Traf3ip1/Traf3ip1 |
Background: |
involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6 |
Zygosity: |
cx |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Publication |
First Author: |
Chen X |
Year: |
2019 |
Journal: |
J Exp Med |
Title: |
IL-17R-EGFR axis links wound healing to tumorigenesis in Lrig1+ stem cells. |
Volume: |
216 |
Issue: |
1 |
Pages: |
195-214 |
|
•
•
•
•
•
|
Publication |
First Author: |
Ho AW |
Year: |
2010 |
Journal: |
J Immunol |
Title: |
IL-17RC is required for immune signaling via an extended SEF/IL-17R signaling domain in the cytoplasmic tail. |
Volume: |
185 |
Issue: |
2 |
Pages: |
1063-70 |
|
•
•
•
•
•
|
Publication |
First Author: |
Bulek K |
Year: |
2011 |
Journal: |
Nat Immunol |
Title: |
The inducible kinase IKKi is required for IL-17-dependent signaling associated with neutrophilia and pulmonary inflammation. |
Volume: |
12 |
Issue: |
9 |
Pages: |
844-52 |
|
•
•
•
•
•
|
Publication |
First Author: |
Valente AJ |
Year: |
2013 |
Journal: |
Free Radic Biol Med |
Title: |
Advanced oxidation protein products induce cardiomyocyte death via Nox2/Rac1/superoxide-dependent TRAF3IP2/JNK signaling. |
Volume: |
60 |
|
Pages: |
125-35 |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Traf3ip2/Traf3ip2 Tnfsf13b/Tnfsf13b |
Background: |
involves: 129 * 129S2/SvPas * BALB/c |
Zygosity: |
cx |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Traf3ip2/Traf3ip2 Tg(CD19-cre/ERT2)1Cgn/? |
Background: |
involves: 129/Sv * BALB/c |
Zygosity: |
cn |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Fcgr2b/Fcgr2b Traf3ip2/Traf3ip2<+> |
Background: |
involves: 129 * 129S4/SvJae * C57BL/6 |
Zygosity: |
cx |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Fcgr2b/Fcgr2b Traf3ip2/Traf3ip2<+> |
Background: |
involves: 129S4/SvJae * BALB/c * C57BL/6 |
Zygosity: |
cx |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Publication |
First Author: |
Hatzoglou A |
Year: |
2000 |
Journal: |
J Immunol |
Title: |
TNF receptor family member BCMA (B cell maturation) associates with TNF receptor-associated factor (TRAF) 1, TRAF2, and TRAF3 and activates NF-kappa B, elk-1, c-Jun N-terminal kinase, and p38 mitogen-activated protein kinase. |
Volume: |
165 |
Issue: |
3 |
Pages: |
1322-30 |
|
•
•
•
•
•
|
Publication |
First Author: |
Sun D |
Year: |
2011 |
Journal: |
Nat Immunol |
Title: |
Treatment with IL-17 prolongs the half-life of chemokine CXCL1 mRNA via the adaptor TRAF5 and the splicing-regulatory factor SF2 (ASF). |
Volume: |
12 |
Issue: |
9 |
Pages: |
853-60 |
|
•
•
•
•
•
|
Publication |
First Author: |
Xie S |
Year: |
2010 |
Journal: |
J Immunol |
Title: |
IL-17 activates the canonical NF-kappaB signaling pathway in autoimmune B cells of BXD2 mice to upregulate the expression of regulators of G-protein signaling 16. |
Volume: |
184 |
Issue: |
5 |
Pages: |
2289-96 |
|
•
•
•
•
•
|
Publication |
First Author: |
Manova K |
Year: |
1998 |
Journal: |
Dev Dyn |
Title: |
Apoptosis in mouse embryos: elevated levels in pregastrulae and in the distal anterior region of gastrulae of normal and mutant mice. |
Volume: |
213 |
Issue: |
3 |
Pages: |
293-308 |
|
•
•
•
•
•
|
Strain |
Attribute String: |
targeted mutation, mutant strain, congenic |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Tcrb/Tcrb Tcrd/Tcrd Traf3ip2/Traf3ip2 |
Background: |
B6.129-Tcrb Traf3ip2 Tcrd |
Zygosity: |
cx |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Fcgr2b/Fcgr2b Traf3ip2/Traf3ip2 Cd79a/Cd79a<+> |
Background: |
involves: 129S4/SvJae * BALB/c * C57BL/6 |
Zygosity: |
cn |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Gt(ROSA)26Sor/Gt(ROSA)26Sor<+> Tg(Cd4-cre)1Cwi/? Traf3ip3/Traf3ip3 |
Background: |
involves: C57BL/6 * C57BL/6N * DBA/2 |
Zygosity: |
cn |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Publication |
First Author: |
Keady BT |
Year: |
2011 |
Journal: |
Mol Biol Cell |
Title: |
IFT20 is required for opsin trafficking and photoreceptor outer segment development. |
Volume: |
22 |
Issue: |
7 |
Pages: |
921-30 |
|
•
•
•
•
•
|
Publication |
First Author: |
Liew GM |
Year: |
2014 |
Journal: |
Dev Cell |
Title: |
The intraflagellar transport protein IFT27 promotes BBSome exit from cilia through the GTPase ARL6/BBS3. |
Volume: |
31 |
Issue: |
3 |
Pages: |
265-78 |
|
•
•
•
•
•
|
Publication |
First Author: |
Qu F |
Year: |
2012 |
Journal: |
Mol Cell Biol |
Title: |
TRAF6-dependent Act1 phosphorylation by the IκB kinase-related kinases suppresses interleukin-17-induced NF-κB activation. |
Volume: |
32 |
Issue: |
19 |
Pages: |
3925-37 |
|
•
•
•
•
•
|
Publication |
First Author: |
Ni CZ |
Year: |
2004 |
Journal: |
J Immunol |
Title: |
Key molecular contacts promote recognition of the BAFF receptor by TNF receptor-associated factor 3: implications for intracellular signaling regulation. |
Volume: |
173 |
Issue: |
12 |
Pages: |
7394-400 |
|
•
•
•
•
•
|
Protein Domain |
Type: |
Domain |
Description: |
Tumor necrosis factor (TNF) receptor associated factor 3 (TRAF3) is a highly versatile regulator that positively controls type I interferon production, but negatively regulates mitogen-activated protein (MAP) kinase activation and non-canonical nuclear factor-kB signalling []. It is a critical regulator of both innate and adaptive immune responses []. TRAF3 plays a role in the regulation of B-cell survival [], in the regulation of antiviral responses [], and in T-cell dependent immune responses []. It is required for normal antibody isotype switching from IgM to IgG []. Differences in the ubiquitination of TRAF3 are the key to the selective production of type I interferons versus proinflammatory cytokines [].TRAF3 contains a RING finger domain, five zinc finger domains, and a TRAF domain. The TRAF domain can be divided into a more divergent N-terminal alpha helical region (TRAF-N), and a highly conserved C-terminal MATH subdomain (TRAF-C) with an eight-stranded β-sandwich structure. TRAF-N mediates trimerization while TRAF-C interacts with receptors []. |
|
•
•
•
•
•
|
Protein Domain |
Type: |
Domain |
Description: |
TRAF3IP1, also known as MIP-T3, which interacts with both microtubules and TRAF3 (tumour necrosis factor receptor-associated factor 3), is conserved from worms to humans. The N-terminal region is the microtubule binding domain and is well-conserved; the C-terminal 100 residues, also well-conserved, constitute the coiled-coil region which binds to TRAF3. The central region of the protein is rich in lysine and glutamic acid and carries KKE motifs which may also be necessary for tubulin-binding, but this region is the least well-conserved []. |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
654
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Publication |
First Author: |
Ling L |
Year: |
2000 |
Journal: |
J Biol Chem |
Title: |
MIP-T3, a novel protein linking tumor necrosis factor receptor-associated factor 3 to the microtubule network. |
Volume: |
275 |
Issue: |
31 |
Pages: |
23852-60 |
|
•
•
•
•
•
|
Protein Domain |
Type: |
Family |
Description: |
TRAF3-interacting protein 1 (TRAF3IP1) recruits TRAF3 (tumour necrosis factor receptor-associated factor 3) and DISC1 (Disrupted-In-Schizophrenia 1) to the microtubules and is conserved from worms to humans []. The N-terminal region is the microtubule binding domain and is well-conserved; the C-terminal 100 residues, also well-conserved, constitute the coiled-coil region which binds to TRAF3. The central region of the protein is rich in lysine and glutamic acid and carries KKE motifs which may also be necessary for tubulin-binding, but this region is the least well-conserved []. In humans, it plays an inhibitory role on IL13 signaling by binding to IL13RA1. It is involved in suppression of IL13-induced STAT6 phosphorylation, transcriptional activity and DNA-binding [, ]. |
|
•
•
•
•
•
|
Publication |
First Author: |
Follit JA |
Year: |
2009 |
Journal: |
Cell Motil Cytoskeleton |
Title: |
Characterization of mouse IFT complex B. |
Volume: |
66 |
Issue: |
8 |
Pages: |
457-68 |
|
•
•
•
•
•
|
Publication |
First Author: |
Ishikawa H |
Year: |
2014 |
Journal: |
Elife |
Title: |
TTC26/DYF13 is an intraflagellar transport protein required for transport of motility-related proteins into flagella. |
Volume: |
3 |
|
Pages: |
e01566 |
|
•
•
•
•
•
|
Publication |
First Author: |
Katoh Y |
Year: |
2016 |
Journal: |
J Biol Chem |
Title: |
Overall Architecture of the Intraflagellar Transport (IFT)-B Complex Containing Cluap1/IFT38 as an Essential Component of the IFT-B Peripheral Subcomplex. |
Volume: |
291 |
Issue: |
21 |
Pages: |
10962-75 |
|
•
•
•
•
•
|
Publication |
First Author: |
Morris JA |
Year: |
2003 |
Journal: |
Hum Mol Genet |
Title: |
DISC1 (Disrupted-In-Schizophrenia 1) is a centrosome-associated protein that interacts with MAP1A, MIPT3, ATF4/5 and NUDEL: regulation and loss of interaction with mutation. |
Volume: |
12 |
Issue: |
13 |
Pages: |
1591-608 |
|
•
•
•
•
•
|
Publication |
First Author: |
Niu Y |
Year: |
2003 |
Journal: |
FEBS Lett |
Title: |
MIP-T3 associates with IL-13Ralpha1 and suppresses STAT6 activation in response to IL-13 stimulation. |
Volume: |
550 |
Issue: |
1-3 |
Pages: |
139-43 |
|
•
•
•
•
•
|
Protein Domain |
Type: |
Homologous_superfamily |
Description: |
TRAF3-interacting protein 1 (TRAF3IP1) recruits TRAF3 (tumour necrosis factor receptor-associated factor 3) and DISC1 (Disrupted-In-Schizophrenia 1) to the microtubules and is conserved from worms to humans []. The N-terminal region is the microtubule binding domain and is well-conserved; the C-terminal 100 residues, also well-conserved, constitute the coiled-coil region which binds to TRAF3. The central region of the protein is rich in lysine and glutamic acid and carries KKE motifs which may also be necessary for tubulin-binding, but this region is the least well-conserved []. In humans, it plays an inhibitory role on IL13 signaling by binding to IL13RA1. It is involved in suppression of IL13-induced STAT6 phosphorylation, transcriptional activity and DNA-binding [, ].This superfamily represents the N-terminal domain of TRAF3-interacting protein 1. |
|
•
•
•
•
•
|